Gregory K. Chow, Senior VP & CFO at Aptose Biosciences Inc. (APTO), bought 15,000 shares at $1.74 ($26K) on 2019-03-13, disclosed to the SEC on 2019-03-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.74 | 10,000 | $17K | 66.0% |
| 2 | $1.79 | 5,000 | $9K | 34.0% |
| Total | $1.76 avg | 15,000 | $26K | 100% |
| Filing → |
| APTO | BUY | 2019-06-07 | $14K | — | Filing → |